72 related articles for article (PubMed ID: 20643514)
1. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee.
Buyyounouski MK; Balter P; Lewis B; D'Ambrosio DJ; Dilling TJ; Miller RC; Schefter T; Tomé W; Harris EE; Price RA; Konski AA; Wallner PE
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):3-10. PubMed ID: 20643514
[No Abstract] [Full Text] [Related]
2. Stereotactic body radiotherapy in lung cancer: an update.
Abreu CE; Ferreira PP; de Moraes FY; Neves WF; Gadia R; Carvalho Hde A
J Bras Pneumol; 2015; 41(4):376-87. PubMed ID: 26398758
[TBL] [Abstract][Full Text] [Related]
3. Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens.
Siva S; Ball D
Oncologist; 2016 Apr; 21(4):393-8. PubMed ID: 26984447
[TBL] [Abstract][Full Text] [Related]
4. Discussion to: Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery.
J Thorac Cardiovasc Surg; 2024 Mar; 167(3):834-835. PubMed ID: 37865894
[No Abstract] [Full Text] [Related]
5. Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer.
Hiley C; Salem A; Batchelor T; McDonald F; Evison M
Thorax; 2020 Mar; 75(3):198-199. PubMed ID: 31964695
[No Abstract] [Full Text] [Related]
6. Stereotactic Body Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer-Is This the Future?
Lester-Coll NH; Park HS
JAMA Oncol; 2024 Mar; 10(3):360-361. PubMed ID: 38206616
[No Abstract] [Full Text] [Related]
7. Stereotactic body radiotherapy for central lung tumours: Author reply.
Adebahr S; Collette S; Shash E; Lambrecht M; Le Pechoux C; Faivre-Finn C; De Ruysscher D; Peulen H; Belderbos J; Dziadziuszko R; Fink C; Guckenberger M; Hurkmans C; Nestle U
Br J Radiol; 2015 Sep; 88(1053):20150532. PubMed ID: 26151618
[No Abstract] [Full Text] [Related]
8. A wedge is still better than stereotactic body radiation therapy in the national cancer database.
Odeh AM; Perez-Tamayo RA; Abdelsattar ZM
J Thorac Cardiovasc Surg; 2024 Apr; 167(4):e100-e101. PubMed ID: 37747399
[No Abstract] [Full Text] [Related]
9. Four-dimensional diffusion-weighted magnetic resonance imaging for stereotactic body radiation therapy in patients with abdominal cancer: abridged secondary publication.
Cai J; Li T; Lee HFV; Chang HC
Hong Kong Med J; 2023 Dec; 29 Suppl 7(6):18-23. PubMed ID: 38148651
[No Abstract] [Full Text] [Related]
10. Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer.
Verma V; Simone CB; Zhen W
Oncologist; 2016 Feb; 21(2):131-3. PubMed ID: 26764248
[TBL] [Abstract][Full Text] [Related]
11. Raman spectroscopy detects metabolic signatures of radiation response and hypoxic fluctuations in non-small cell lung cancer.
Van Nest SJ; Nicholson LM; Pavey N; Hindi MN; Brolo AG; Jirasek A; Lum JJ
BMC Cancer; 2019 May; 19(1):474. PubMed ID: 31109312
[TBL] [Abstract][Full Text] [Related]
12. Implications for high-precision dose radiation therapy planning or limited surgical resection after percutaneous computed tomography-guided lung nodule biopsy using a tract sealant.
de Groot PM; Shroff GS; Ahrar J; Sabloff BS; Gladish GM; Moran C; Gupta S; Gladish GW; Chang JY; Erasmus JJ
Adv Radiat Oncol; 2018; 3(2):139-145. PubMed ID: 29904738
[TBL] [Abstract][Full Text] [Related]
13. Quality and safety in stereotactic radiosurgery and stereotactic body radiation therapy: can more be done?
Solberg TD; Medin PM
J Radiosurg SBRT; 2011; 1(1):13-19. PubMed ID: 29296293
[TBL] [Abstract][Full Text] [Related]
14. Lobectomy: no port at all?
Ren Y; Jiao Y; Zheng X
Ann Transl Med; 2017 May; 5(Suppl 1):S9. PubMed ID: 28567391
[No Abstract] [Full Text] [Related]
15. The impact of emphysema on dosimetric parameters for stereotactic body radiotherapy of the lung.
Ochiai S; Nomoto Y; Yamashita Y; Inoue T; Murashima S; Hasegawa D; Kurita Y; Watanabe Y; Toyomasu Y; Kawamura T; Takada A; Noriko ; Kobayashi S; Sakuma H
J Radiat Res; 2016 Sep; 57(5):555-566. PubMed ID: 27380802
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of three-dimensional conformal radiotherapy, intensity modulated radiotherapy, and helical tomotherapy for lung stereotactic body radiotherapy.
Kinhikar RA; Ghadi YG; Sahoo P; Laskar SG; Deshpande DD; Shrivastava SK; Agarwal J
J Med Phys; 2015; 40(4):190-7. PubMed ID: 26865754
[TBL] [Abstract][Full Text] [Related]
17. Oligometastatic disease, the curative challenge in radiation oncology.
Palacios-Eito A; García-Cabezas S
World J Clin Oncol; 2015 Aug; 6(4):30-4. PubMed ID: 26266098
[TBL] [Abstract][Full Text] [Related]
18. Lung metastases in oligometastatic patients: outcome with stereotactic body radiation therapy (SBRT).
García-Cabezas S; Bueno C; Rivin E; Roldán JM; Palacios-Eito A
Clin Transl Oncol; 2015 Aug; 17(8):668-72. PubMed ID: 26022130
[TBL] [Abstract][Full Text] [Related]
19. Optimal set of grid size and angular increment for practical dose calculation using the dynamic conformal arc technique: a systematic evaluation of the dosimetric effects in lung stereotactic body radiation therapy.
Park JY; Kim S; Park HJ; Lee JW; Kim YS; Suh TS
Radiat Oncol; 2014 Jan; 9():5. PubMed ID: 24387278
[TBL] [Abstract][Full Text] [Related]
20. Negative margin technique - a novel planning strategy to improve dose conformation in SBRT using dynamic conformal arc delivery.
Kim S; Kim T; Ko SJ; Serago C; Smith A; Vallow LA; Peterson JL; Lee R
J Appl Clin Med Phys; 2013 Sep; 14(5):79-89. PubMed ID: 24036861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
